4D Molecular Therapeutics, Inc.

FDMT · NASDAQ
Analyze with AI
$7.50+$0.20 (+2.74%)
At close:Jan 9, 2026, 9:00 PM UTC
$7.40−$0.10 (−1.33%)
After hours:Jan 12, 2026, 1:24 PM UTC
P/E TTM-2.01
P/B TTM1.14
P/S TTM11,675.63
Dividend Yield0%
EPS-2.98
Beta2.983
Valuation
PEG Ratio0.32
FCF Yield-52.48%
EV / EBITDA-1.43
Quality
ROIC-58.68%
Gross Margin-5,846.67%
Cash Conv. Ratio0.88
Growth
Revenue 3Y CAGR-77.22%
FCF Growth-76.13%
Safety
Net Debt / EBITDA0.12
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-1,404.15

4D Molecular Therapeutics, Inc. (FDMT) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is 4D Molecular Therapeutics, Inc. (FDMT) stock price today?

As of Jan 9, 2026, 9:00 PM UTC, 4D Molecular Therapeutics, Inc. (FDMT) stock is trading at $7.50. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date FDMT stock quotes for informed trading decisions.

What is 4D Molecular Therapeutics, Inc.'s market capitalization?

4D Molecular Therapeutics, Inc. (FDMT) has a market capitalization of approximately $350.3M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare 4D Molecular Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the FDMT stock price changes.

What is the 52-week range for 4D Molecular Therapeutics, Inc. stock?

4D Molecular Therapeutics, Inc. (FDMT) stock has traded in a 52-week range of $2.24 — $12.34. The 52-week range shows the highest and lowest prices at which FDMT traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current 4D Molecular Therapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does 4D Molecular Therapeutics, Inc. stock have?

4D Molecular Therapeutics, Inc. (FDMT) stock recently traded approximately 632.2K shares. Trading volume indicates market liquidity and investor interest in FDMT. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting 4D Molecular Therapeutics, Inc. stock.

Does 4D Molecular Therapeutics, Inc. pay dividends to shareholders?

Yes, 4D Molecular Therapeutics, Inc. (FDMT) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate 4D Molecular Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is 4D Molecular Therapeutics, Inc.'s intraday price range?

Today, 4D Molecular Therapeutics, Inc. (FDMT) stock has traded in a range of $7.34 — $7.60. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring FDMT's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get 4D Molecular Therapeutics, Inc. stock data?

AlphaPilot sources real-time FDMT stock quotes, fundamental financial data, and historical price charts for 4D Molecular Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The 4D Molecular Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of FDMT stock performance.